Comment on Kuyper et al.--Atenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysis

Can J Cardiol. 2015 Mar;31(3):365.e5. doi: 10.1016/j.cjca.2014.11.015. Epub 2014 Nov 20.

Authors

Mingxing Li¹, Deqi Jiang², Shanshan Yu¹, Yan Wang¹, Yong Wang³

Affiliations

¹ Department of Pharmacy, Zhu Jiang Hospital, Southern Medical University, Guangzhou, China.
² Department of Pharmacy, Zhu Jiang Hospital, Southern Medical University, Guangzhou, China; Department of Biopharmaceutical, Yulin Normal University, Yulin, China.
³ Department of Pharmacy, Zhu Jiang Hospital, Southern Medical University, Guangzhou, China. Electronic address: yongwh2005@163.com.

PMID: 25746028
DOI: 10.1016/j.cjca.2014.11.015

No abstract available

Publication types

Letter
Comment

MeSH terms

Adrenergic beta-Antagonists / administration & dosage*
Atenolol / administration & dosage*
Atenolol / adverse effects*
Calcium Channel Blockers / administration & dosage*
Humans
Hypertension / drug therapy*
Stroke / etiology*

Substances

Adrenergic beta-Antagonists
Calcium Channel Blockers
Atenolol